tiprankstipranks
GE Healthcare Technologies Inc (GEHC)
NASDAQ:GEHC
US Market

GE Healthcare Technologies Inc (GEHC) Stock Price & Analysis

750 Followers

GEHC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$62.30 - $94.47
Previous Close$84.97
Volume1.82M
Average Volume (3M)3.57M
Market Cap
$38.79B
Enterprise Value$45.81B
Total Cash (Recent Filing)$2.50B
Total Debt (Recent Filing)$9.44B
Price to Earnings (P/E)28.1
Beta1.30
Apr 30, 2024
Dividend Yield0.14%
Share Statistics
EPS (TTM)3.02
Shares Outstanding455,357,229
10 Day Avg. Volume2,397,476
30 Day Avg. Volume3,565,410
Standard Deviation0.10
R-Squared0.23
Alpha0.00815
Financial Highlights & Ratios
Price to Book (P/B)-5.54
Price to Sales (P/S)7.45
Price to Cash Flow (P/CF)9.30
P/FCF Ratio8.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.34
Enterprise Value/Gross Profit2.80
Enterprise Value/Ebitda13.04
Forecast
Price Target Upside14.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11

Bulls Say, Bears Say

Bulls Say
Policy ImpactThe recent State Council's plan in China encourages qualified medical institutions to accelerate the renewal and transformation of medical equipment, a positive development for healthcare equipment and novel drug companies.
Product DevelopmentGEHC will focus on launching new products and solutions that incorporate AI and digital technologies.
Stock ValuationGEHC stock trades at a discount compared to peers, suggesting potential for valuation increase.
Bears Say
Financial PerformanceAt ~19x NTM P/E with a 3-year rev. and EPS CAGR below GEHC's peers, there is limited room for multiple expansion at current levels.
Industry ComparisonGEHC's exposure to China and the challenging peer results suggest potential disappointment in their upcoming results.
Market DynamicsGEHC's stock was down following the announcement of Anhui province's move to centralized procurement.
---

Financials

Annual

Ownership Overview

7.69%32.39%22.51%37.41%
22.51% Other Institutional Investors
37.41% Public Companies and Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

GEHC FAQ

What was GE Healthcare Technologies Inc’s price range in the past 12 months?
GE Healthcare Technologies Inc lowest stock price was $62.30 and its highest was $94.47 in the past 12 months.
    What is GE Healthcare Technologies Inc’s market cap?
    Currently, no data Available
    When is GE Healthcare Technologies Inc’s upcoming earnings report date?
    GE Healthcare Technologies Inc’s upcoming earnings report date is Apr 30, 2024 which is in 10 days.
      How were GE Healthcare Technologies Inc’s earnings last quarter?
      GE Healthcare Technologies Inc released its earnings results on Feb 06, 2024. The company reported $1.18 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.11.
        Is GE Healthcare Technologies Inc overvalued?
        According to Wall Street analysts GE Healthcare Technologies Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does GE Healthcare Technologies Inc pay dividends?
          GE Healthcare Technologies Inc pays a Thriceyearly dividend of $0.03 which represents an annual dividend yield of 0.14%. See more information on GE Healthcare Technologies Inc dividends here
            What is GE Healthcare Technologies Inc’s EPS estimate?
            GE Healthcare Technologies Inc’s EPS estimate is $0.91.
              How many shares outstanding does GE Healthcare Technologies Inc have?
              GE Healthcare Technologies Inc has 455,357,240 shares outstanding.
                What happened to GE Healthcare Technologies Inc’s price movement after its last earnings report?
                GE Healthcare Technologies Inc reported an EPS of $1.18 in its last earnings report, beating expectations of $1.07. Following the earnings report the stock price went up 11.652%.
                  Which hedge fund is a major shareholder of GE Healthcare Technologies Inc?
                  Among the largest hedge funds holding GE Healthcare Technologies Inc’s share is Dodge & Cox. It holds GE Healthcare Technologies Inc’s shares valued at 1B.
                    ---

                    Company Description

                    GE Healthcare Technologies Inc

                    GE HealthCare Technologies Inc is a global medical technology, pharmaceutical diagnostics, and digital solutions innovator company.
                    ---

                    GEHC Company Deck

                    ---

                    GEHC Earnings Call

                    Q4 2024
                    0:00 / 0:00
                    ---

                    GEHC Revenue Breakdown

                    54.12%54.12%17.68%16.07%11.79%0.34%
                    54.12% Imaging
                    17.68% Ultrasound
                    16.07% PCS
                    11.79% PDx
                    0.34% Other
                    tipranks
                    ---

                    GEHC Stock 12 Months Forecast

                    Average Price Target

                    $97.10
                    ▲(14.28% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"67":"$67","78":"$78","89":"$89","100":"$100","111":"$111"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":110,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$110.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":97.1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$97.10</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":86,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$86.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[67,78,89,100,111],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2023","6":"Oct<br/>2023","9":"Jan<br/>2024","12":"Apr<br/>2024","25":"Apr<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,88.44,90.09846153846154,91.75692307692307,93.41538461538461,95.07384615384615,96.73230769230769,98.39076923076922,100.04923076923077,101.70769230769231,103.36615384615385,105.02461538461539,106.68307692307692,108.34153846153846,{"y":110,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,88.44,89.10615384615384,89.77230769230769,90.43846153846154,91.10461538461539,91.77076923076923,92.43692307692308,93.10307692307691,93.76923076923076,94.4353846153846,95.10153846153845,95.7676923076923,96.43384615384615,{"y":97.1,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,88.44,88.2523076923077,88.06461538461538,87.87692307692308,87.68923076923076,87.50153846153846,87.31384615384616,87.12615384615384,86.93846153846154,86.75076923076924,86.56307692307692,86.37538461538462,86.1876923076923,{"y":86,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":82.21,"date":1681430400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.84,"date":1683244800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.84,"date":1685664000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.49,"date":1688688000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.81,"date":1691107200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.17,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.38,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.52,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.36,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.56,"date":1704412800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":73.88,"date":1706832000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":92.69,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.44,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Koninklijke Philips
                    Danaher
                    Boston Scientific
                    Pfizer

                    Best Analysts Covering GEHC

                    1 Year
                    Larry BiegelsenWells Fargo
                    1 Year Success Rate
                    7/8 ratings generated profit
                    88%
                    1 Year Average Return
                    +17.19%
                    reiterated a buy rating last month
                    Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +17.19% per trade.
                    Popular Stocks
                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis